Telih Boyiri

Title: The Innovative Contributions of Telih Boyiri

Introduction

Telih Boyiri is a notable inventor based in Richmond, VA, who has made significant contributions to the field of biochemistry through his innovative patents. With a total of two patents to his name, Boyiri's work focuses on allosteric modifications that have potential applications in pharmaceuticals.

Latest Patents

Boyiri's latest patents include "Allosteric inhibitors of pyruvate kinase" and "Aldehydic agents for allosteric modification of hemoglobin." The first patent identifies chemical structures that allosterically modify pyruvate kinase, either inhibiting or activating its enzymatic activity. These compounds hold promise for treating various diseases and disorders by influencing metabolic processes, particularly in the glycolytic pathway and ATP-utilizing pathways. The second patent describes chemical compounds that interact within the central water cavity of hemoglobin, allowing for allosteric modifications that shift hemoglobin between tense and relaxed states. This innovation utilizes aldehydes and carboxylic acids to form covalent and ionic bonds with specific amino acid residues in hemoglobin, enhancing its functionality.

Career Highlights

Throughout his career, Telih Boyiri has worked with esteemed institutions such as Virginia Commonwealth University and the Center for Innovative Technology. His research and inventions have contributed to advancements in the understanding of metabolic processes and hemoglobin functionality.

Collaborations

Boyiri has collaborated with notable individuals in his field, including Donald J Abraham and Richmond E Danso-Danquah. These collaborations have further enriched his research and innovation efforts.

Conclusion

Telih Boyiri's contributions to biochemistry through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to impact the treatment of various diseases, showcasing the importance of innovation in the field.